Celldex Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Celldex Therapeutics Inc
TickerCLDX
CIK #0000744218
CUSIP15117B202
SectorLife Sciences - In Vitro & In Vivo Diagnostic Substances
Address119 Fourth Ave, Needham, MA 02494
Source [EDGAR]
CIK Filing 2011 - 2025
[0000744218] 10-K
[0000744218] 10-Q
[0000744218] 3
[0000744218] 4
[0000744218] 8-K
[0000744218] D
[0000744218] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Point72 Asset Management LP Celldex Therapeutics Inc [2025-07-10] 0.0
Commodore Capital LP Celldex Therapeutics Inc [2025-04-10] 0.0
Price T Rowe Associates Inc /MD/ Celldex Therapeutics Inc [2025-02-14] 0.0
Kynam Capital Management LP Celldex Therapeutics Inc [2024-02-14] 5.5
Eventide Asset Management LLC Celldex Therapeutics Inc [2024-02-14] 6.64
Polar Capital Holdings PLC Celldex Therapeutics Inc [2024-02-13] 5.73
Point72 Asset Management LP Celldex Therapeutics Inc [2023-11-20] 6.6
Wellington Management Group LLP Celldex Therapeutics Inc [2023-02-06] 0.87
Viking Global Investors LP Celldex Therapeutics Inc [2022-06-10] 5.1
State Street Corp Celldex Therapeutics Inc [2022-02-10] 5.07
Vanguard Group Inc Celldex Therapeutics Inc [2022-02-09] 5.17
BlackRock Inc Celldex Therapeutics Inc [2022-02-04] 6.6
FMR LLC Celldex Therapeutics Inc [2021-10-12] 0.0
Cowen Financial Products LLC Celldex Therapeutics Inc [2021-02-25] 5.0939
Redmile Group LLC Celldex Therapeutics Inc [2021-02-16] 6.9
Logos Global Management LP Celldex Therapeutics Inc [2020-10-22] 4.3
Adage Capital Partners GP LLC Celldex Therapeutics Inc [2020-07-24] 5.01
Biotechnology Value Fund L P Celldex Therapeutics Inc [2020-06-26] 3.8
RTW Investments LP Celldex Therapeutics Inc [2020-06-19] 0.95
Ikarian Capital LLC Celldex Therapeutics Inc [2020-06-18] 7.1
Renaissance Technologies LLC Celldex Therapeutics Inc [2020-02-12] 6.91
Columbia Wanger Asset Management LLC Celldex Therapeutics Inc [2017-02-10] 5.1
KLP Enterprises LLC Celldex Therapeutics Inc [2016-12-09] 5.7
State Street Corp Celldex Therapeutics Inc [2016-04-08] 8.67
First Trust Portfolios LP Celldex Therapeutics Inc [2016-01-27] 7.53
Vanguard Group Inc Celldex Therapeutics Inc [2014-02-12] 5.59
Franklin Resources Inc Celldex Therapeutics Inc [2014-02-11] 0.0
FMR LLC Celldex Therapeutics Inc [2013-09-10] 0.0
SAC Capital Advisors LP Celldex Therapeutics Inc [2013-04-22] 4.9
SAC Capital Advisors LP Celldex Therapeutics Inc [2013-04-05] 4.9
Prudential Financial Inc Celldex Therapeutics Inc [2013-02-13] 5.9
Jennison Associates LLC Celldex Therapeutics Inc [2013-02-11] 5.7
BlackRock Inc Celldex Therapeutics Inc [2013-01-30] 8.65
Ridgeback Capital Investments LP Celldex Therapeutics Inc [2012-12-28] 6.1
Form 3/4/5 Filer 2011 - 2025
Jimenez Freddy A.
Celldex Therapeutics, Inc.
Cavanaugh Sarah
Heath-Chiozzi Margo
Martin Samuel Bates
Crowley Elizabeth
Neil Garry Arthur
Conrad Herbert J
Marucci Anthony S
Torres Denice
Jain Rita
Penner Harry Jr
Cohen Cheryl
Brownlie Keith L
Pepin Ronald
Young Diane C.
Keler Tibor
Marino James J
Wright Richard M.
Shoos Karen L.
McMahon Gerald PhD
Ellberger Larry
Davis Thomas Andrew
LaVallee Theresa
Catlin Avery W
van den Broek Richard
Elston George
Shannon Timothy M
Form 13F Holdings
Firm Period DFND Voting Shares
Kynam Capital Management LP [2025-06-30] SOLE 6,100,729 6,100,729
BlackRock, Inc. [2025-06-30] SOLE 5,324,712 5,550,016
FMR LLC [2025-06-30] DFND 5,434,732 5,439,118
Wellington Management Group LLP [2025-06-30] DFND 0 5,232,326
Vanguard Group Inc [2025-06-30] SOLE 0 3,852,637
Commodore Capital LP [2025-06-30] SOLE 3,450,000 3,450,000
Bellevue Group AG [2025-06-30] DFND 3,307,569 3,307,569
Point72 Asset Management LP [2025-06-30] DFND 0 2,801,721
State Street Corp [2025-06-30] DFND 2,219,399 2,405,495
Deep Track Capital LP [2025-06-30] SOLE 2,000,000 2,000,000
Vestal Point Capital LP [2025-06-30] SOLE 1,750,000 1,750,000
Geode Capital Management LLC [2025-06-30] DFND 1,672,980 1,672,980
Woodline Partners LP [2025-06-30] SOLE 1,500,455 1,500,455
Eventide Asset Management LLC [2025-06-30] SOLE 1,356,186 1,356,186
Pictet Asset Management Holding SA [2025-06-30] SOLE 1,164,748 1,300,329
Polar Capital Holdings Plc [2025-06-30] DFND 1,228,435 1,228,435
Novo Holdings A/S [2025-06-30] SOLE 1,200,000 1,200,000
UBS Group AG [2025-06-30] DFND 841,171 841,246
Eversept Partners LP [2025-06-30] SOLE 838,736 838,736
Fisher Asset Management LLC [2025-06-30] DFND 266,240 822,208
Rock Springs Capital Management LP [2025-06-30] SOLE 812,653 812,653
American Century Companies Inc [2025-06-30] DFND 666,688 779,985
Goldman Sachs Group Inc [2025-06-30] DFND 724,886 727,504
Baker Bros Advisors LP [2025-06-30] SOLE 665,370 665,370
Morgan Stanley [2025-06-30] DFND 639,684 661,518
D. E. Shaw & Co., Inc. [2025-06-30] DFND 640,957 645,657
Logos Global Management LP [2025-06-30] SOLE 600,000 600,000
Northern Trust Corp [2025-06-30] DFND 565,851 565,851
Charles Schwab Investment Management Inc [2025-06-30] SOLE 553,081 553,081
5AM Venture Management LLC [2025-06-30] SOLE 497,270 497,270
Prev | Page 5 | Next
Terms | Privacy | Guide
tony@aum13f.com